Protease Crosstalk with Integrins: the Urokinase Receptor Paradigm

Summary

Migratory cells use both adhesion receptors and proteolytic enzymes to regulate their interaction with and response to extracellular matrices. Cooperation between integrins and proteases operates at several levels: integrin signaling induces proteases, proteases co-localize with integrins, and proteases regulate the interface between integrins and the intracellular cytoskeleton. One protease system intimately connected to integrins is the urokinase/urokinase receptor(uPAR)/plasmin system. Recent studies indicate urokinase promotes the ligand-like binding of its receptor to a set of β₁ and β₂ integrins, this binding in turn affecting integrin signaling and cell migration. The glycolipid anchor of uPAR associates with cholesterol-rich membrane rafts. Binding of uPAR to integrins may enrich integrin clusters with signaling molecules such as src-family kinases that localize to rafts and are important to integrin function. Signals derived from integrin/uPAR complexes promote the function of other integrins. Thus the urokinase/plasmin system coordinates with integrins to regulate cell: matrix interactions.

Key words

Urokinase - integrin - signaling - receptor

• References

• 1 Lochter A, Navre M, Werb Z, Bissell MJ. alpha₁ and alpha₂ integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol Biol Cell 1999; 10: 271-82.
• 2 Horwitz AR, Werb Z. Cell-to-cell contact and extracellular matrix cell adhesion and the extracellular matrix: recent progress and emerging themes. Curr Opin Cell Biol 1998; 10: 563-5.
• 3 Chapman HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997; 9: 714-24.
• 4 Palecek SP, Horwitz AF, Laufenburger DA. Kinetic model for integrin-mediated adhesion release during cell migration. Ann Biomed Eng 1999; 27: 219-35.
• 5 Werb ZTP, Behrendtsen O, Crowley E, Damsky CH. Signal transduction through the fibronectin receptor induce collagenase and stromelysin gene expression. J Cell Biol 1989; 109: 877-89.
• 6 Ghosh S, Brown R, Jones JC, Ellerbroek SM, Stack MS. Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha₃ beta₁ integrin in oral keratinocytes. J Biol Chem 2000; 275: 23869-76.
• 7 Huang S, New L, Pan Z, Han J, Nemerow GR. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mirogen-activated protein kinase activaty. J Biol Chem 2000; 275: 12266-72.
• 8 Morini M, Mottolese M, Ferrari N, Ghiorzo F, Buglioni S, Mortarini R. et al. The alpha₃beta₁ integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer 2000; 87: 336-42.
• 9 Rifkin DB, Mazzieri R, Munger JS, Noguera I, Sung J. Proteolytic control of growth factor availability. APMIS 1999; 107: 80-5.
• 10 Carmeliet P, Moons L, Dewerchin M, Mackman N, Luther T, Breier G. et al. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system. Ann N Y Acad Sci 1997; 811: 191-206.
• 11 Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG. et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha_v beta₃ . Cell 1996; 85: 683-93.
• 12 Senior RM, Hinek A, Griffin GL, Pipoly DJ, Crouch EC, Mecham RP. Neutrophils show chemotaxis to type IV collagen and its 7S domain and contain a 67 kD type IV collagen binding protein with lectin properties. Am J Respir Cell Mol Biol 1989; 1: 479-87.
• 13 Senior RM, Griffin GL, Mecham RP, Wrenn DS, Prasad KU, Urry DW. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol 1984; 99: 870-4.
• 14 Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000; 52: 237-68.
• 15 Hagedorn M, Bikfalvi A. Target molecules for anti-angiogenic therapy. from basic research to clinical trials. Crit Rev Oncol Hematol 2000; 34: 89-110.
• 16 Carragher NO, Fincham VJ, Riley D, Frame MC. Cleavage of focal adhesion kinase by different proteases during src-regulated transformation and apoptosis: Distinct roles for calpain and caspases. J Biol Chem 2001; 276: 4270-5.
• 17 Kulkarni S, Saido TC, Suzuki K, Fox JE. Calpain mediates integrin-induced signaling at a point upstream of Rho family members. J Biol Chem 1999; 274: 21265-75.
• 18 Huttenlocher A, Palecek SP, Lu Q, Zhang W, Mellgren RL, Lauffenburger DA. et al. Regulation of cell migration by the calcium-dependent protease calpain. J Biol Chem 1997; 272: 32719-22.
• 19 Arthur JS, Elce JS, Hegadorn C, Williams K, Greer PA. Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol 2000; 20: 4474-81.
• 20 Blasi F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 1993; 15: 105-11.
• 21 Vaheri A, Stephens RW, Salonen EM, Pollanen J, Tapiovaara H. Plasminogen activation at the cell surface-matrix interface. Cell Differ Dev 1990; 32: 255-62.
• 22 Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV. et al. Regulation of integrin function by the urokinase receptor. Science 1996; 273: 1551-5.
• 23 Xue W, Kindzelskii AL, Todd 3rd RF, Petty HR. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J Immunol 1994; 152: 4630-40.
• 24 Aguirre Ghiso JA, Kovalski K, Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 1999; 147: 89-104.
• 25 Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidle UH, Majdic O. et al. Urokinase plasminogen activator receptor, beta₂-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 1995; 181: 1381-90.
• 26 Xue W, Mizukami I, Todd 3rd RF, Petty HR. Urokinase-type plasminogen activator receptor associate with beta₁ and beta₃ integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res 1997; 57: 1682-9.
• 27 Yebra M, Goretzki L, Pfeifer M, Mueller BM. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. Exp Cell Res 1999; 250: 231-40.
• 28 Springer TA. Folding of the N-terminal, ligand-binding region of integrin alpha- subunits into a beta-propeller domain. Proc Natl Acad Sci USA 1997; 94: 65-72.
• 29 Irie A, Kamata T, Takada Y. Multiple loop structures critical for ligand binding of the integrin alpha₄ subunit in the upper face of the beta-propeller mode 1. Proc Natl Acad Sci USA 1997; 94: 7198-203.
• 30 Lu C, Oxvig C, Springer TA. The structure of the beta-propeller domain and C-terminal region of the integrin alphaM subunit. Dependence on beta subunit association and prediction of domains. J Biol Chem 1998; 273: 15138-47.
• 31 Oxvig C, Springer TA. Experimental support for a beta-propeller domain in integrin alpha-subunits and a calcium binding site on its lower surface. Proc Natl Acad Sci USA 1998; 95: 4870-5.
• 32 Zang Q, Lu C, Huang C, Takagi J, Springer TA. The top of the inserted-like domain of the integrin lymphocyte function-associated antigen-1 beta subunit contacts the alpha subunit beta-propeller domain near beta-sheet 3. J Biol Chem 2000; 275: 22202-12.
• 33 Simon DIWY, Chen Z, Rao NK, Rosenberg S, Chapman HA. Identification of a urokinase receptor-integrin interaction site: promiscuous regulator of integrin function. J Biol Chem 2000; 275: 10228-34.
• 34 Tarui T, Mazar AP, Cines DB, Takada Y. Urokinase receptor (uPAR/ CD87) is a ligand for integrins and mediates cell-cell interaction. J Biol Chem 2001; 276: 3983-90.
• 35 Wei YEJ, Kreidberg JA, Chapman HA. Urokinase receptors promote beta₁ integrin function through interactions with the integrin alpha3beta1. Submitted 2001
• 36 Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is co-expressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995; 55: 4132-9.
• 37 Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA. et al. Alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor. J Cell Biol 1995; 131: 1609-22.
• 38 Wijnberg MJ, Quax PH, Nieuwenbroek NM, Verheijen JH. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein. Thromb Haemost 1997; 78: 880-6.
• 39 Nguyen DH, Hussaini IM, Gonias SL. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J Biol Chem 1998; 273: 8502-7.
• 40 Sitrin RG, Todd 3rd RF, Albrecht E, Gyetko MR. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 1996; 97: 1942-51.
• 41 Trigwell S, Wood L, Jones P. Soluble urokinase receptor promotes cell adhesion and requires tyrosine-92 for activation of p56/59 (hck). Biochem Biophys Res Commun 2000; 278: 440-6.
• 42 Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 1995; 11: 549-99.
• 43 Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285: 1028-32.
• 44 Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
• 45 Dumler I, Weis A, Mayboroda OA, Maasch C, Jerke U, Haller H. et al. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J Biol Chem 1998; 273: 315-21.
• 46 Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR. Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J Biol Chem 1997; 272: 28563-7.
• 47 Nguyen DH, Catling AD, Webb DJ, Sankovic M, Walker LA, Somlyo AV. et al. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol 1999; 146: 149-64.
• 48 Ossowski L, Aguirre-Ghiso JA. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 2000; 12: 613-20.
• 49 Degryse B, Resnati M, Rabbani SA, Villa A, Fazioli F, Blasi F. Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. Blood 1999; 94: 649-62.
• 50 Harder T, Simons K. Caveolae, DIGs, and the dynamics of sphingolipidcholesterol microdomains. Curr Opin Cell Biol 1997; 9: 534-42.
• 51 Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing “preassembled signaling complexes” at the plasma membrane. J Biol Chem 1998; 273: 5419-22.
• 52 Wei Y, Yang X, Liu Q, Wilkins JA, Chapman HA. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol 1999; 144: 1285-94.
• 53 Yauch RL, Berditchevsky F, Harler MB, Reichner J, Hemler ME. Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration. Mol Biol Cell 1998; 9: 2751-65.
• 54 Yauch RL, Kazarov AR, Desai B, Lee RT, Hemler ME. Direct extracellular contact between integrin alpha(3)beta(1) and TM4SF protein CD151. J Biol Chem 2000; 275: 9230-8.
• 55 Yabra M, Parry GCN, Stromblad S, Mackman N, Rosenberg S, Mueller BM. et al. Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta3-directed cell migration. J Biol Chem 1996; 271: 29393-9.
• 56 Gyetko MR, Sud S, Kendall T, Fuller JA, Newstead MW, Standiford TJ. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J Immunol 2000; 165: 1513-9.
• 57 May AE, Kanse SM, Lund LR, Gisler RH, Imhof BA, Preissner KT. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. J Exp Med 1998; 188: 1029-37.
• 58 Waltz DA, Fujita RM, Yang X, Natkin L, Zhuo S, Gerard CJ. et al. Nonproteolytic role for the urokinase receptor in cellular migration in vivo. Am J Respir Cell Mol Biol 2000; 22: 316-22.
• 59 Green JM, Zhelesnyak A, Chung J, Lindberg FP, Sarfati M, Frazier WA. et al. Role of cholesterol in formation and function of a signaling complex involving alphavbeta3, integrin-associated protein (CD47), and heterotri-metric G proteins. J Cell Biol 1999; 146: 673-82.
• 60 Frazier WA, Gao AG, Dimitry J, Chung J, Brown EJ, Lindberg FP. et al. The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi. J Biol Chem 1999; 274: 8554-60.
• 61 Mueller SC, Ghersi G, Akiyama SK, Sang QX, Howard L, Pineiro-Sanchez M. et al. A novel protease-docking function of integrin at invadopodia. J Biol Chem 1999; 274: 24947-52.